Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03013998
Title Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Beat AML, LLC

acute myeloid leukemia


Azacitidine + Enasidenib

Azacitidine + Entospletinib

Cytarabine + Daunorubicin + Samalizumab

Azacitidine + BI 836858

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.